Your cookie settings for

We use cookies and other technologies (incl. 3rd party services) to offer you website features, to understand the usage and to optimize our offering as well as providing you with individualized offers and ads. For more information, check out our privacy policy and our cookie policy, where you can change your cookie settings at any time.

Change settings
Adjust your privacy settings for
Required Cookies

Absolutely necessary to ensure that you can use the site, e.g.

  • Store your privacy settings and language preferences
  • Session handling
  • Website-Login
  • Shopping basket
Functional & Performance Cookies

Recommended to use the site optimally, e.g.

  • Search history
  • Website-analytics
  • Individual recommendation of offers and content within our site
  • Testing new features
Advertising Cookies

Services which offer extended analysis of usage behaviour within and outside of our website.

  • Advertising services & trackers
  • Social network integration

New name for Labtec GmbH

tesa Group pharma division consolidates its strengths

Topic: Industry

On February 1, 2013, Labtec GmbH begins operating under the new name of tesa Labtec GmbH. The global tesa Group integrates development and production of transdermal patches and fast-dissolving oral films under one roof.

tesa SE acquired Labtec GmbH at the end of 2008 as a wholly owned affiliate. Founded in 1990, the company specializes in developing transdermal patches (Transfilm®) and fast-dissolving oral films (Rapidfilm®).

Concurrently, the technology group invested around EUR 18 million in a clean room unit at the tesa plant in Hamburg-Hausbruch accommodating a 6000 square meters, state-of-the-art pharmaceutical production facility. The site is one of the most modern in Europe and covers every aspect of pharmaceutical development and production processes including adhesive mixing and compounding, coating, converting, and packaging. The regulatory approval to manufacture pharmaceutical products was obtained in March 2011, and since then numerous clinical trial products were manufactured. Development capacity was doubled which proved to be crucial for the successful expansion of partnerships with internationally renowned pharmaceutical companies, both from the branded and generic sectors.

Effective February 1, the pharmaceuticals unit of tesa Werk Hamburg GmbH, Labtec GmbH, and the pharma business unit at tesa SE have been consolidated to form the new tesa Labtec GmbH. The tesa affiliate’s operating units continue to be located in Hamburg and Langenfeld. The Managing Directors in charge are Dr. Ingo Lehrke, Joachim Suesse and Dr. Heinrich Koch.

Read more

Press Downloads

Here you can add all documents and media files to the download cart at once. (Zip File)


PR New name for Labtec

File type
File size
15 kB


“Solutions for Pharma”: tesa Labtec GmbH launches its new key visual and Internet presence ( on February 1.

tesa Labtec GmbH - Keyvisual

File type
File size
1.7 MB

“Solutions for Pharma”: tesa Labtec GmbH launches its new key visual and Internet presence ( on February 1.

File type
File size
1.7 MB
Copyright status
This media asset may only be used for editorial purposes, a commercial use is excluded. All tesa media assets that are reproduced for editorial purposes must bear the copyright notice "© tesa SE. All rights reserved". An electronic processing is only permitted with the prior consent of tesa SE. May be reproduced freely. We ask for a copy.

Press Contacts

Manager Corporate Communications
Gunnar von der Geest

Phone: +49 40 88899 5296

Fax: +49 40 88899 185296

Contact me